EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+13.11%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$933M
AUM Growth
+$933M
(+25%)
Cap. Flow
+$92.4M
Cap. Flow
% of AUM
9.9%
Top 10 Holdings %
Top 10 Hldgs %
79.57%
Holding
39
New
10
Increased
7
Reduced
7
Closed
7
Top Buys
1 |
Arcus Biosciences
RCUS
|
$34.5M |
2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$21.3M |
3 |
Wave Life Sciences
WVE
|
$21M |
4 |
UroGen Pharma
URGN
|
$20M |
5 |
Agios Pharmaceuticals
AGIO
|
$14.1M |
Top Sells
1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$32.8M |
2 |
Ascendis Pharma
ASND
|
$18.6M |
3 |
Galapagos
GLPG
|
$10.4M |
4 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$8.18M |
5 |
Rhythm Pharmaceuticals
RYTM
|
$4.21M |
Sector Composition
1 | Healthcare | 93.34% |